%0 Journal Article
%T Patrones de prescripci車n de factor de transferencia en 11 hospitales de Ciudad de La Habana, 2002 Patterns of prescription of the transfer factor in 11 hospitals located in the City of Havana, 2002
%A Mar赤a Aida Cruz Barrios
%A Blanca Nieves Rodr赤guez Montiel
%A Juan A Furones Mourrelle
%A Addis D Mart赤n de la Riva
%J Revista Cubana de Salud P迆blica
%D 2005
%I Centro Nacional de Informaci車n de Ciencias M谷dicas
%X El factor de transferencia (FT) es un inmunoestimulante que se emplea en una amplia gama de enfermedades. A pesar de que sus indicaciones est芍n reguladas, la oferta resulta habitualmente insuficiente por lo que se sospecha una sobre utilizaci車n de este f芍rmaco en la pr芍ctica cl赤nica habitual, por tal motivo se realiz車 un estudio de utilizaci車n del medicamento en 11 hospitales de Ciudad de La Habana para caracterizar la prescripci車n de este f芍rmaco postcomercializaci車n. Se analiz車 la prescripci車n en 425 pacientes encontrando que el 94,1 % recibi車 el medicamento en la consulta externa del hospital, el 70,8 % de las prescripciones no est芍 dentro de las aprobadas en el registro sanitario, el 56,7 % de las indicaciones fueron en enfermedades infecciosas recurrentes y se emplearon 34 esquemas de tratamiento diferentes. Concluimos que el uso de FT en la pr芍ctica cl赤nica habitual no se ajusta a las regulaciones aprobadas para su empleo The transfer factor is an immunostimulant that is used in a wide array of diseases. Despite the fact that indications for this product are regulated, offer is generally insufficient and it is suspected that this drug is overused in daily clinical practice. Therefore, a drug utilization study was conducted in 11 hospitals located in the City of Havana to characterize the after-market prescription of this pharmaceutical. Prescribing practices were analyzed in 425 patients, which yielded that 94.1% was given the drug by the outpatient service, 70.8% of prescriptions were not included in those approved by the health registry; 56.7% was directed to treat recurrent infectious diseases and 34 different therapeutic schemes were followed. It was concluded that the use of TF in the present clinical practice does not comply with the regulations passed for this product
%K Factor de transferencia
%K estudio de utilizaci車n de medicamentos
%K farmacoepidemiolog赤a
%K inmunoestimulantes
%K h芍bitos de prescripci車n
%K transfer factor
%K drug use study
%K pharmacoepidemiology
%K immunostimulant
%K prescription practices
%U http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662005000400004